Inflammation on NAFLD progression
(A) TNF-α or LPS activates each receptor, such as TNFR and LPS4 or 9, leading to increase NF-κB phosphorylation through the activation of MAPK, STAT3, JNK, or AMPK expression. Additionally, the production of reactive oxygen species (ROS) contributes to mitochondrial dysfunction and inflammasome activation, which in turn accelerate IL-1β maturation and secretion. (B) miR-34a inhibited MAPK-mediated NF-κB phosphorylation via activation of TLR4, which is triggered by LPS or high-glucose levels. Besides, NF-κB-mediated TNF-α induction activates its receptor and activated inflammatory signaling pathway. However, this signaling pathway is inactivated by miR-125b/TRNAIP3-mediated TNF-α receptor ubiquitination. In addition, IL-6 secretion by NF-κB activation increased phosphorylation of STAT3 and activated miR-233-enriched exosome which was source of IL-6 over production. Accelerated inflammatory signaling pathway induced PERK-mediated eIF2α phosphorylation suppressed by miR-26a and miR-26a suppressed eIF2α-activated NF-κB p65 translocation into nucleus. Moreover, high-glucose activated IRS-1/AKT signaling pathway and FOXO3 that suppressed by miR-122-5p activation. (C) The environment of the intestine and liver is closely linked to the disruption of gut microbiota, which can be induced by dysregulation of diets. Briefly, LPS secreted by disruption of gut microbiota increased gut inflammation through inactivating AMPK/PPARβ/δ mechanisms. Moreover, dephosphorylation of AMPK-mediated PPARα suppression caused by disruption of gut microbiota increased PGC1α-mediated lipid metabolisms and induced liver steatosis. In addition, activation of PPARγ stabilized cellular homeostasis through induction of IL-10 and iNOS mRNA expression. Furthermore, LPS comes from dysfunction of gut microbiota activated TLR4-mediated NF-κB signaling pathway in hepatocyte through blood flow in portal vein. NAFLD, non-alcoholic fatty liver disease; TNF-α, tumor necrosis factor-α; NF-κB, nuclear factor of kappa photopolypeptide enhancer; MAPK, mitogen-activated protein kinase; STAT3, signal transducer and activator of transcription 3; AMPK, AMP-activated protein kinase; IL, interleukin; TLR, toll-like receptor; IRS-1, insulin receptor substrate 1; PPAR, peroxisome proliferator-activated receptor; PGC1α, PPARγ coactivator-1α; iNOS, inducible nitric oxide synthase; ER, endoplasmic reticulum; HFD, high-fat diet; FFA, free fatty acid
Publication
Experimental model and novel therapeutic targets for non-alcoholic fatty liver disease development (2023) Yujin Jin, et al. Korean J Physiol Pharmacol. 2023 Jul 1;27(4). Figure: F2.| Organism | Group | Word | Match | Source | NCBI Symbol | NCBI ID |
|---|---|---|---|---|---|---|
| Homo sapiens | Primates | ERK1 | ERK1 | ncbigene_synonym | MAPK3 | 5595 |
| Homo sapiens | Primates | ERK1/2 | ERK2 | ncbigene_synonym | MAPK1 | 5594 |
| Homo sapiens | Primates | STAT3 | STAT3 | ncbigene_symbol | STAT3 | 6774 |
| Homo sapiens | Primates | JNK | JNK | ncbigene_synonym | MAPK8 | 5599 |
| Homo sapiens | Primates | JNK | JNK | famplex_relations | MAPK9 | 5601 |
| Homo sapiens | Primates | JNK | JNK | famplex_relations | MAPK10 | 5602 |
| Homo sapiens | Primates | AMPK | AMPK | ncbigene_synonym | PRKAA1 | 5562 |
| Homo sapiens | Primates | AMPK | AMPK | ncbigene_synonym | PRKAA2 | 5563 |
| Homo sapiens | Primates | AMPK | AMPK | ncbigene_synonym | PRKAB1 | 5564 |
| Homo sapiens | Primates | AMPK | AMPK | famplex_relations | PRKAB2 | 5565 |
| Homo sapiens | Primates | AMPK | AMPK | famplex_relations | PRKAG1 | 5571 |
| Homo sapiens | Primates | AMPK | AMPK | famplex_relations | PRKAG2 | 51422 |
| Homo sapiens | Primates | AMPK | AMPK | famplex_relations | PRKAG3 | 53632 |
| Homo sapiens | Primates | TLR4 | TLR4 | ncbigene_symbol | TLR4 | 7099 |
| Homo sapiens | Primates | TNF- | TNF | ncbigene_symbol | TNF | 7124 |
| Homo sapiens | Primates | IRS-1 | IRS1 | ncbigene_symbol | IRS1 | 3667 |
| Homo sapiens | Primates | MAPK | MAPK | famplex_relations | MAPK11 | 5600 |
| Homo sapiens | Primates | MAPK | MAPK | famplex_relations | MAPK12 | 6300 |
| Homo sapiens | Primates | MAPK | MAPK | famplex_relations | MAPK13 | 5603 |
| Homo sapiens | Primates | MAPK | MAPK | famplex_relations | MAPK14 | 1432 |
| Homo sapiens | Primates | PI3K | PI3K | ncbigene_synonym | PIK3CA | 5290 |
| Homo sapiens | Primates | PI3K | PI3K | ncbigene_synonym | PIK3CB | 5291 |
| Homo sapiens | Primates | PI3K | PI3K | ncbigene_synonym | PIK3CD | 5293 |
| Homo sapiens | Primates | PI3K | PI3K | ncbigene_synonym | PIK3CG | 5294 |
| Homo sapiens | Primates | PI3K | PI3K | famplex_relations | PIK3R3 | 8503 |
| Homo sapiens | Primates | PI3K | PI3K | famplex_relations | PIK3R4 | 30849 |
| Homo sapiens | Primates | PI3K | PI3K | famplex_relations | PIK3R5 | 23533 |
| Homo sapiens | Primates | PI3K | PI3K | famplex_relations | PIK3R6 | 146850 |
| Homo sapiens | Primates | PI3K | PI3K | famplex_relations | PIK3R1 | 5295 |
| Homo sapiens | Primates | PI3K | PI3K | famplex_relations | PIK3R2 | 5296 |
| Homo sapiens | Primates | PI3K/AKT | AKT | ncbigene_synonym | AKT1 | 207 |
| Homo sapiens | Primates | PI3K/AKT | AKT | famplex_relations | AKT2 | 208 |
| Homo sapiens | Primates | PI3K/AKT | AKT | famplex_relations | AKT3 | 10000 |
| Homo sapiens | Primates | TNFAIP3 | TNFAIP3 | ncbigene_symbol | TNFAIP3 | 7128 |
| Homo sapiens | Primates | PERK | PERK | ncbigene_synonym | EIF2AK3 | 9451 |
| Homo sapiens | Primates | TLR9 | TLR9 | ncbigene_symbol | TLR9 | 54106 |
| Homo sapiens | Primates | IL-18 | IL-18 | ncbigene_synonym | IL18 | 3606 |
| Homo sapiens | Primates | PPAR | PPAR | ncbigene_synonym | PPARA | 5465 |
| Homo sapiens | Primates | PPAR | PPAR | famplex_relations | PPARD | 5467 |
| Homo sapiens | Primates | PPAR | PPAR | famplex_relations | PPARG | 5468 |
| Homo sapiens | Primates | IL-4 | IL-4 | ncbigene_synonym | IL4 | 3565 |
| Homo sapiens | Primates | L-18 | L18 | ncbigene_synonym | RPL18 | 6141 |
| Homo sapiens | Primates | L-18 | L18 | ncbigene_synonym | IGKV1D-13 | 28902 |
| Homo sapiens | Primates | L-18 | L18 | ncbigene_synonym | IGKV1-13 | 28939 |
| Word | Match | MeSH | Name | ChEBI |
|---|---|---|---|---|
| ROS | ROS | chebi:26523 | ||
| TNF-a | TNF-a | chebi:197439 | ||
| PERK | PERK | tetrachloroethene | chebi:17300 | |
| TNF-a | TNF-a | chebi:197439 |
Disease mentions
| Word | Match | MeSH | Name | DOID |
|---|